Skip to main content
Georgia Cancer Info Logo
Donate
Georgia Cancer Info Logo
About Georgia CORENews & HappeningsWays to Give
Advancing ResearchExplore Clinical TrialsCollaboration Opportunities
ScreeningGeorgia Genetics ProgramEducation & NavigationSurvivorship

Check your hereditary breast & ovarian cancer risk with our easy Genetic Screening Tool.

Start risk assessment
Search ResourcesFind Cancer Centers
Donate
Georgia Cancer Info Logo

Contact us

+1-404-523-8735info@georgiacancerinfo.org
999 Peachtree St NE, Suite 400Atlanta, GA 30309

Sign up for news and announcements

  • Home
  • About
  • Contact
  • Facebook
  • LinkedIn
  • Instagram

© 2005 - 2026 Georgia Center for Oncology Research and Education. All Rights Reserved.

PrivacyTerms & Conditions
Amelia A. Langston, MD
  1. About Us/
  2. Amelia A. Langston, MD

Amelia A. Langston, MD

Chair

Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory Winship Cancer Institute

Board certified in internal medicine, hematology and medical oncology, Amelia A. Langston, MD treats patients with leukemia, myelodysplastic syndrome, lymphoma, graft-versus-host disease (GVHD), aplastic anemia and HIV-related malignancies. Dr. Langston is a practicing physician with Emory Healthcare since 1998.

Dr. Langston holds memberships with American Association for the Advancement of Science and American Society of Hematology.

Dr. Langston received her Medical Degree from Washington University in St. Louis, Missouri. She completed her residency in Internal Medicine at Duke University Medical Center in Durham, North Carolina, followed by a Medical Oncology fellowship at the University of Washington Hospitals.

Amelia A. Langston, MD

Keep up to date with Georgia CORE on LinkedIn

Real stories from patients, survivors, and advocates across Georgia.

Follow on LinkedIn
Oct. stakeholder session: Should Georgia have a cancer clinical trials roundtable?

Day 2 of an impressive convening of Georgia CORE partners representing the cancer research, care provider, patient navigation and advocacy communities. Each stakeholder session was an opportunity for these groups to come together and discuss how to carry the recommendations forward of the Georgia House Study Committee on Access to Cancer Care on day 1; and the state of cancer clinical trials in Georgia on day 2. Be on the look out for the forthcoming report of these impactful two days!